保龄宝(002286.SZ)：取得乳果糖原料药药品生产许可证

Core Viewpoint - The company, Baolingbao (002286.SZ), has obtained a Drug Manufacturing License from the Shandong Provincial Drug Administration, which accelerates the application, registration, and market launch process for its first active pharmaceutical ingredient, lactulose, marking the beginning of the company's diversification in raw materials [1] Group 1 - The acquisition of the Drug Manufacturing License is a significant regulatory milestone for the company [1] - The approval facilitates the subsequent steps for the company's first raw material drug, lactulose [1] - This development represents the start of the company's strategy to diversify its raw material offerings [1]